ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Headache,Headaches NEC,Headaches,Nerv,N
2,1,Headache,Headaches NEC,Headaches,Nerv,N
3,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
4,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
5,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6,2,Headache,Headaches NEC,Headaches,Nerv,N
6,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
8,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
8,2,Oedema mouth,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
8,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8,4,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
9,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
9,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
10,1,Hypoglycaemic unconsciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
10,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
10,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
11,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
11,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
11,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
11,5,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
11,6,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
12,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
12,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
12,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
12,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
12,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
12,7,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
13,1,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
13,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
14,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
14,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
14,3,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
14,4,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
14,5,Hypoglycaemic seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
14,6,Hypoglycaemic unconsciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
14,7,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
15,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
16,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
16,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
17,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
18,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
18,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
19,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
19,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
19,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
20,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
20,2,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
20,3,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
20,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
21,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
21,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
22,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
22,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
22,3,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
22,4,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
22,5,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
23,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
23,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
23,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
24,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
25,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
25,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
25,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
25,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
25,5,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
26,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
26,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
26,3,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
26,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
26,5,Costochondritis,Cartilage disorders,"Tendon, ligament and cartilage disorders",Musc,N
26,6,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
26,7,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
26,8,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
26,9,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
26,10,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
26,11,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
26,12,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
26,13,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
26,14,Iron deficiency anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
26,15,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
26,16,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
26,17,Pituitary tumour,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
26,18,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
26,19,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
27,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
27,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
27,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
27,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
27,5,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
28,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
28,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
28,3,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
29,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
29,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
29,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
29,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
29,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
29,6,Vasodilation procedure,Vascular therapeutic procedures NEC,Vascular therapeutic procedures,Surg,N
30,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
30,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
31,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
32,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
32,2,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
32,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
32,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
33,1,Cardiac septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
33,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
33,3,Inferior vena cava dilatation,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
33,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
33,5,Trisomy 21,Autosomal chromosomal abnormalities,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
34,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
35,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
35,2,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
36,1,Type III immune complex mediated reaction,Allergic conditions NEC,Allergic conditions,Immun,N
37,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
37,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
38,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
39,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
39,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
39,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
40,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
41,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
42,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
42,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
42,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
42,4,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
43,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
43,2,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
43,3,Near death experience,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
43,4,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
44,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
44,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
44,3,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
44,4,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
44,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
45,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
45,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
46,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
46,2,Hypoglycaemia neonatal,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
46,3,Jaundice neonatal,Neonatal hepatobiliary disorders,Neonatal and perinatal conditions,Preg,N
46,4,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
47,1,Exposure via breast milk,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
47,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
47,3,Hypoglycaemia neonatal,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
47,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
47,5,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
48,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
48,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
49,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
49,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
49,3,Headache,Headaches NEC,Headaches,Nerv,N
49,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
49,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
49,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
49,7,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
50,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
50,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
50,3,Headache,Headaches NEC,Headaches,Nerv,N
50,4,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
50,5,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
50,6,Ketoacidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
50,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
51,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
51,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
51,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
51,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
52,1,Device issue,Device issues NEC,Device issues,Prod,N
52,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
52,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
53,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
53,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
54,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
54,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
54,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
54,4,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
54,5,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
54,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
54,7,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
54,8,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
54,9,Ear disorder,Ear disorders NEC,Aural disorders NEC,Ear,N
54,10,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
54,11,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
54,12,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
54,13,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
54,14,Nasal disorder,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
54,15,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
54,16,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
55,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
55,2,Insulin resistance,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
56,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
56,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
57,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
57,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
57,3,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
57,4,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
57,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
57,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
58,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
58,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
58,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
58,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
59,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
59,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
59,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
59,4,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
60,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
61,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
61,2,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
61,3,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
61,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
61,5,Hiatus hernia,Diaphragmatic hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
61,6,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
61,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
61,8,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
62,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
62,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
62,3,Product preparation error,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
62,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
63,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
63,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
63,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
63,4,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
64,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
64,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
64,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
64,4,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
65,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
65,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
65,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
65,4,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
66,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
66,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
66,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
66,4,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
67,1,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
68,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
68,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
68,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
68,4,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
68,5,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
68,6,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
68,7,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
68,8,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
68,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
68,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
68,11,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
68,12,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
68,13,Headache,Headaches NEC,Headaches,Nerv,N
68,14,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
68,15,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
68,16,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
68,17,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
68,18,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
69,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
69,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
69,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
70,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
70,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
70,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
70,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
70,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
70,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
71,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
72,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
72,2,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
73,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
73,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
73,3,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
74,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
75,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
76,1,Anti-insulin antibody,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
76,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
76,3,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
76,4,Hyperinsulinaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
76,5,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
76,6,Insulin resistance,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
77,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
77,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
77,3,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
77,4,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
77,5,Insulin resistance,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
78,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
78,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
79,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
80,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
80,2,Device issue,Device issues NEC,Device issues,Prod,N
80,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
81,1,Asphyxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
